about
Over 50 Years of Fibrinogen ConcentrateGene polymorphisms in association with emerging cardiovascular risk markers in adult womenFibrinogen β-derived Bβ(15-42) peptide protects against kidney ischemia/reperfusion injuryModeling a hydropic recipient twin in twin-twin transfusion syndrome.Fibrinogen beta variants confer protection against coronary artery disease in a Greek case-control studyWhole and refined grain intakes are related to inflammatory protein concentrations in human plasma.Clinical correlation between N-terminal pro-B-type natriuretic peptide and angiographic coronary atherosclerosis.Heterozygosity for fibrinogen results in efficient resolution of kidney ischemia reperfusion injury.Consolidated and emerging inflammatory markers in coronary artery diseaseInflammation, kidney function and albuminuria in the Framingham Offspring cohort.Plasma fibrinogen lever and risk of coronary heart disease among Chinese population: a systematic review and meta-analysisFibrinogen excretion in the urine and immunoreactivity in the kidney serves as a translational biomarker for acute kidney injury.The Effect of a Single Bout Circuit Resistance Exercise on Homocysteine, hs-CRP and Fibrinogen in Sedentary Middle Aged MenFibrinogen levels in trauma patients during the first seven days after fibrinogen concentrate therapy: a retrospective study.The role of established and emerging risk factors in peripheral vascular graft occlusion.Time course of haemostatic effects of fibrinogen concentrate administration in aortic surgery.Emerging families of biomarkers for coronary artery disease: inflammatory mediatorsHaemostatic markers are associated with measures of vascular disease in adults with hypertension.Fibrinogen plasma concentration is an independent marker of haemodynamic impairment in chronic thromboembolic pulmonary hypertension.Cryoprecipitate: an outmoded treatment?The NF-κB pathway: regulation of the instability of atherosclerotic plaques activated by Fg, Fb, and FDPs.Relationships of oxidized HDL with blood coagulation and fibrinolysis in patients with type 2 diabetes mellitus.Atomic force microscopy as a tool to evaluate the risk of cardiovascular diseases in patients.Raised plasma fibrinogen concentration in patients with abdominal aortic aneurysm.Anti-inflammatory, Antithrombotic and Cardiac Remodeling Preventive Effects of Eugenol in Isoproterenol-Induced Myocardial Infarction in Wistar Rat.Association of increased fibrinogen concentration with impaired activation of anticoagulant protein C.Determinants of risk factors of atherosclerosis in the postinfarction period: the Tallinn MI study.
P2860
Q26796205-E43F4ECF-1212-4516-96E2-C238087592D1Q28393721-F827A5F3-C88A-4A80-83D7-C99711C417C9Q28573774-85F5D7A0-EE15-4C85-82F7-D44AD0E1CCE0Q31127055-629CBAA6-1893-4BD6-815F-FD0C90F6EA43Q33532288-8CBB5953-6D4A-4494-AC62-F3A510D40C06Q33652908-B7500A1A-80A9-4F5D-A5AB-464838E3999CQ33729553-3AEAC100-1D2F-4ED8-8318-173A4B635C71Q34429646-8DC8D538-CDC9-42DD-B215-653BC76F4A7FQ35019922-F4A7C713-07E8-453C-9AD5-451F056439FEQ35025400-468D882E-8B9C-49A3-AE8C-88D53362A4F3Q35835815-32F67F1D-8A0F-496D-AB3D-53172DC04C0CQ36204158-A218FFA1-57EF-4C5F-AB5F-796CA785406DQ36652513-0BD17F82-A298-47A4-AD82-CD08677EA323Q36679150-A7824F12-AA86-4776-AA77-6791D37B0A1BQ36808026-008ADD88-750E-41F8-939E-D3A977633BCBQ36854348-21EA4E87-312A-404A-A612-364758A4BE18Q37115819-AD33B93E-B078-4A35-9C20-33F8A27A85A4Q37266804-5FE77A74-45C2-40FA-A20E-000515808BCFQ37738172-EB54316F-C3FE-451D-8F0D-0DA82234CE75Q38044961-73A74A87-34DB-4276-89F5-CADE5898D3A8Q42961174-07BAEB5B-EC75-4213-A397-D982A33C0FA1Q49787716-BC98402C-FA8F-4EE1-8754-DB6C1DC6786FQ50240094-D196954E-7ADD-491B-B524-036E1DE9A0C0Q52854977-ABE4BEFC-3C5C-44D5-A31E-EAECCDB4436FQ52915425-38BEF6C1-B847-41CD-B18A-FCBC84554E8CQ53640161-06F3A668-1F84-4D0B-BE29-28114C92175FQ54430137-29D61C64-E6C2-467B-955E-AD8EB0AB5FF1
P2860
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Fibrinogen--marker or mediator of vascular disease?
@ast
Fibrinogen--marker or mediator of vascular disease?
@en
type
label
Fibrinogen--marker or mediator of vascular disease?
@ast
Fibrinogen--marker or mediator of vascular disease?
@en
prefLabel
Fibrinogen--marker or mediator of vascular disease?
@ast
Fibrinogen--marker or mediator of vascular disease?
@en
P2860
P1433
P1476
Fibrinogen--marker or mediator of vascular disease?
@en
P2093
Walter H Reinhart
P2860
P304
P356
10.1191/1358863X03VM494RA
P577
2003-01-01T00:00:00Z